Taysha Gene Therapies Inc (TSHA) — Free Cash Flow Generation Index

Latest as of December 2022: 0.84x

Taysha Gene Therapies Inc (TSHA) has a Free Cash Flow Generation Index of 0.84x as of December 2022. Free cash flow of $11.97 Million represents 1% of operating cash flow ($14.28 Million). See TSHA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

FCF Generation Index

0.84x

Free Cash Flow / Operating CF

Free Cash Flow

$11.97 Million

USD

Operating Cash Flow

$14.28 Million

USD

Capital Expenditures

$2.31 Million

USD

Taysha Gene Therapies Inc Free Cash Flow Generation Index (2019–2019)

Historical FCF Generation Index trend for Taysha Gene Therapies Inc across 1 annual periods. Explore TSHA cash flow to debt ratio to assess how comfortably operating cash covers total debt obligations.

Annual Free Cash Flow Generation for Taysha Gene Therapies Inc (2019–2019)

Year-by-year Free Cash Flow Generation Index for Taysha Gene Therapies Inc. For the full company profile including market capitalisation, see TSHA company net worth.

Year	FCG Index	Free Cash Flow (USD)	Operating CF	Capital Expenditures	YoY Change
2019	1.00x	$135.00K	$135.00K	$82.00K	—

FCG Index = Free Cash Flow / Operating Cash Flow. FCF = Operating CF + Capital Expenditures (capex stored negative).